The Task Force on Prescription Drug and Heroin Abuse made a number of recommendations which affect prescribers and their use of the Prescription Monitoring Program.
- Senate Bill 513 made it mandatory to check the PMP, with a few exceptions, for a course of treatment that includes the prescribing of opioids expected to last more than 14 days. This bill also expands the ability of prescribers to register delegates (other office personnel) to access the PMP.
- Other actions of the 2016 General Assembly allow the Board of Medicine to require up to 2 hours of CME on opioids, and will allow the PMP to report outlier opioid prescribing behavior to the enforcement division of the Department of Health Professions.
- Beginning January 1, 2017 pharmacies and other dispensers will be required to report to the PMP within 24 hours of dispensing, rather than 7 days.
For more information, visit the Prescription Monitoring Program online.